Log in

Coherus Biosciences News Headlines (NASDAQ:CHRS)

$19.27
+0.08 (+0.42 %)
(As of 10/20/2019 04:00 PM ET)
Today's Range
$18.50
Now: $19.27
$19.31
50-Day Range
$18.29
MA: $20.54
$23.75
52-Week Range
$8.32
Now: $19.27
$23.91
Volume597,024 shs
Average Volume1.49 million shs
Market Capitalization$1.34 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.94

Headlines

Coherus Biosciences (NASDAQ CHRS) News Headlines

Source:
DateHeadline
Insider Selling: Coherus Biosciences Inc (NASDAQ:CHRS) CFO Sells 3,159 Shares of StockInsider Selling: Coherus Biosciences Inc (NASDAQ:CHRS) CFO Sells 3,159 Shares of Stock
www.americanbankingnews.com - October 18 at 6:16 PM
Insider Selling: Coherus Biosciences Inc (NASDAQ:CHRS) COO Sells 2,500 Shares of StockInsider Selling: Coherus Biosciences Inc (NASDAQ:CHRS) COO Sells 2,500 Shares of Stock
www.americanbankingnews.com - October 16 at 6:50 PM
Coherus Biosciences Inc (NASDAQ:CHRS) Sees Large Decrease in Short InterestCoherus Biosciences Inc (NASDAQ:CHRS) Sees Large Decrease in Short Interest
www.americanbankingnews.com - October 16 at 1:20 PM
Coherus BioSciences to Report Third Quarter Financial Results on November 6thCoherus BioSciences to Report Third Quarter Financial Results on November 6th
finance.yahoo.com - October 15 at 12:33 PM
Coherus Biosciences Inc (NASDAQ:CHRS) Expected to Announce Quarterly Sales of $93.58 MillionCoherus Biosciences Inc (NASDAQ:CHRS) Expected to Announce Quarterly Sales of $93.58 Million
www.americanbankingnews.com - October 15 at 2:40 AM
Coherus Biosciences (NASDAQ:CHRS) and Biogen (NASDAQ:BIIB) Critical SurveyCoherus Biosciences (NASDAQ:CHRS) and Biogen (NASDAQ:BIIB) Critical Survey
www.americanbankingnews.com - October 9 at 1:33 AM
Coherus Biosciences Inc (NASDAQ:CHRS) Given Average Recommendation of "Buy" by AnalystsCoherus Biosciences Inc (NASDAQ:CHRS) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - October 8 at 7:46 AM
Contrasting Voyager Therapeutics (NASDAQ:VYGR) and Coherus Biosciences (NASDAQ:CHRS)Contrasting Voyager Therapeutics (NASDAQ:VYGR) and Coherus Biosciences (NASDAQ:CHRS)
www.americanbankingnews.com - October 6 at 5:10 PM
Mizuho Analysts Give Coherus Biosciences (NASDAQ:CHRS) a $43.00 Price TargetMizuho Analysts Give Coherus Biosciences (NASDAQ:CHRS) a $43.00 Price Target
www.americanbankingnews.com - October 3 at 1:25 AM
Financial Survey: Coherus Biosciences (NASDAQ:CHRS) versus Gamida Cell (NASDAQ:GMDA)Financial Survey: Coherus Biosciences (NASDAQ:CHRS) versus Gamida Cell (NASDAQ:GMDA)
www.americanbankingnews.com - September 27 at 4:15 AM
Investors Buy High Volume of Call Options on Coherus Biosciences (NASDAQ:CHRS)Investors Buy High Volume of Call Options on Coherus Biosciences (NASDAQ:CHRS)
www.americanbankingnews.com - September 26 at 7:31 AM
Coherus Biosciences Inc (NASDAQ:CHRS) CFO Jean-Frederic Viret Sells 740 SharesCoherus Biosciences Inc (NASDAQ:CHRS) CFO Jean-Frederic Viret Sells 740 Shares
www.americanbankingnews.com - September 25 at 7:03 PM
How This IBD Stock Of The Day Is Rattling Medical Giants Amgen, MylanHow This IBD Stock Of The Day Is Rattling Medical Giants Amgen, Mylan
finance.yahoo.com - September 25 at 3:31 PM
The Play On Coherus BiosciencesThe Play On Coherus Biosciences
seekingalpha.com - September 13 at 3:21 PM
Coherus BioSciences (CHRS) Upgraded to Buy: Heres What You Should KnowCoherus BioSciences (CHRS) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - September 11 at 5:19 AM
Stocks To Watch: Is Biosimilars Leader Coherus Biosciences Set To Rebound?Stocks To Watch: Is Biosimilars Leader Coherus Biosciences Set To Rebound?
finance.yahoo.com - August 28 at 5:54 PM
Is Coherus BioSciences (NASDAQ:CHRS) Using Too Much Debt?Is Coherus BioSciences (NASDAQ:CHRS) Using Too Much Debt?
finance.yahoo.com - August 22 at 5:35 PM
Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in SeptemberCoherus BioSciences Management to Present at Two Investor Healthcare Conferences in September
finance.yahoo.com - August 21 at 11:34 PM
Coherus up 14% on strong ramp of Neulasta biosimilarCoherus up 14% on strong ramp of Neulasta biosimilar
seekingalpha.com - August 2 at 5:41 PM
Edited Transcript of CHRS earnings conference call or presentation 1-Aug-19 8:30pm GMTEdited Transcript of CHRS earnings conference call or presentation 1-Aug-19 8:30pm GMT
finance.yahoo.com - August 2 at 10:05 AM
Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q2 2019 Results - Earnings Call TranscriptCoherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 1 at 10:45 PM
Coherus BioSciences (CHRS) Beats Q2 Earnings and Revenue EstimatesCoherus BioSciences (CHRS) Beats Q2 Earnings and Revenue Estimates
finance.yahoo.com - August 1 at 10:45 PM
Coherus BioSciences, Inc. (CHRS) Q2 2019 Earnings Call TranscriptCoherus BioSciences, Inc. (CHRS) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 1 at 10:45 PM
Coherus BioSciences Reports Corporate Highlights and Second Quarter 2019 Financial ResultsCoherus BioSciences Reports Corporate Highlights and Second Quarter 2019 Financial Results
finance.yahoo.com - August 1 at 5:44 PM
The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On EarningsThe Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings
finance.yahoo.com - July 30 at 10:45 AM
Coherus BioSciences Reports Victory in Pegfilgrastim Patent DisputeCoherus BioSciences Reports Victory in Pegfilgrastim Patent Dispute
finance.yahoo.com - July 29 at 10:40 PM
Coherus BioSciences Announces Unaudited Second Quarter 2019 UDENYCA® Net Sales of $79 Million to $84 MillionCoherus BioSciences Announces Unaudited Second Quarter 2019 UDENYCA® Net Sales of $79 Million to $84 Million
www.nasdaq.com - July 8 at 9:39 AM
Coherus BioSciences to Report Second Quarter Financial Results on August 1stCoherus BioSciences to Report Second Quarter Financial Results on August 1st
finance.yahoo.com - July 8 at 9:39 AM
Coherus BioSciences Announces Unaudited Second Quarter 2019 UDENYCA® Net Sales of $79 Million to $84 MillionCoherus BioSciences Announces Unaudited Second Quarter 2019 UDENYCA® Net Sales of $79 Million to $84 Million
finance.yahoo.com - July 8 at 9:39 AM
Coherus BioSciences Production Exceeds Four-Hundred Thousand UDENYCA® (pegfilgrastim-cbqv) Pre-Filled SyringesCoherus BioSciences Production Exceeds Four-Hundred Thousand UDENYCA® (pegfilgrastim-cbqv) Pre-Filled Syringes
finance.yahoo.com - July 1 at 5:14 PM
Coherus BioSciences (CHRS) Upgraded to Strong Buy: Heres WhyCoherus BioSciences (CHRS) Upgraded to Strong Buy: Here's Why
finance.yahoo.com - June 27 at 5:34 PM
Coherus BioSciences (CHRS) Upgraded to Strong Buy: Here's WhyCoherus BioSciences (CHRS) Upgraded to Strong Buy: Here's Why
finance.yahoo.com - June 27 at 5:34 PM
Amgen (AMGN) Offers to Acquire Drug Discovery PlatformAmgen (AMGN) Offers to Acquire Drug Discovery Platform
finance.yahoo.com - May 23 at 5:30 PM
Did Coherus BioSciencess (NASDAQ:CHRS) Share Price Deserve to Gain 29%?Did Coherus BioSciences's (NASDAQ:CHRS) Share Price Deserve to Gain 29%?
finance.yahoo.com - May 23 at 10:28 AM
Did Coherus BioSciences's (NASDAQ:CHRS) Share Price Deserve to Gain 29%?Did Coherus BioSciences's (NASDAQ:CHRS) Share Price Deserve to Gain 29%?
finance.yahoo.com - May 22 at 5:21 PM
Coherus BioSciences Management to Present at Jefferies 2019 Global Healthcare ConferenceCoherus BioSciences Management to Present at Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 22 at 10:55 AM
2 Drug Stocks to Buy as Health Care Suffers, According to JPMorgan2 Drug Stocks to Buy as Health Care Suffers, According to JPMorgan
finance.yahoo.com - May 13 at 5:35 PM
Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q1 2019 Results - Earnings Call TranscriptCoherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 10:42 AM
Coherus BioSciences (CHRS) Reports Q1 Loss, Tops Revenue EstimatesCoherus BioSciences (CHRS) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 10 at 10:42 AM
Coherus BioSciences, Inc. (CHRS) Q1 2019 Earnings Call TranscriptCoherus BioSciences, Inc. (CHRS) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 10 at 10:42 AM
Edited Transcript of CHRS earnings conference call or presentation 9-May-19 8:30pm GMTEdited Transcript of CHRS earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 10:42 AM
Coherus BioSciences Reports Corporate Highlights and First Quarter 2019 Financial ResultsCoherus BioSciences Reports Corporate Highlights and First Quarter 2019 Financial Results
www.marketwatch.com - May 9 at 5:07 PM
Did Hedge Funds Drop The Ball On Coherus Biosciences Inc (CHRS) ?Did Hedge Funds Drop The Ball On Coherus Biosciences Inc (CHRS) ?
finance.yahoo.com - May 8 at 5:07 PM
Coherus BioSciences and Amgen Settle Trade Secrets ActionCoherus BioSciences and Amgen Settle Trade Secrets Action
finance.yahoo.com - May 2 at 5:13 PM
Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare ConferencesCoherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences
finance.yahoo.com - May 2 at 10:37 AM
Moving Average Crossover Alert: Coherus BioSciencesMoving Average Crossover Alert: Coherus BioSciences
finance.yahoo.com - April 26 at 10:19 AM
The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciencesThe Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences
finance.yahoo.com - April 25 at 10:17 AM
5 Biotech Stocks Defying the Medicare-for-All Scare5 Biotech Stocks Defying the Medicare-for-All Scare
finance.yahoo.com - April 24 at 10:17 AM
Coherus (CHRS) Catches Eye: Stock Jumps 6.9%Coherus (CHRS) Catches Eye: Stock Jumps 6.9%
finance.yahoo.com - April 9 at 11:52 AM
Heres Why Coherus BioSciences Popped TodayHere's Why Coherus BioSciences Popped Today
www.fool.com - April 8 at 5:25 PM
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Featured Article: Intrinsic Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel